Doxorubicin/ifosfamideLack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1967卷 / 1期

关键词：

D O I：

10.1007/s40278-023-43958-3

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：151 / 151

相关论文

共 50 条

[31] Carboplatin/Etoposide/IfosfamideLack of efficacy and drug intolerance : case report
Reactions Weekly, 2024, 2034 (1) : 93 - 93
[32] Cisplatin/etoposide/ifosfamideLack of efficacy and tumour lysis syndrome: case report
Reactions Weekly, 2022, 1926 (1) : 169 - 169
[33] Doxorubicin/olaratumabLack of efficacy: case report
Reactions Weekly, 2022, 1893 (1) : 128 - 128
[34] Doxorubicin/pazopanibLack of efficacy : case report
Reactions Weekly, 2024, 2020 (1) : 183 - 183
[35] Doxorubicin/taxanesLack of efficacy: case report
Reactions Weekly, 2024, 2026 (1) : 116 - 116
[36] Doxorubicin/eribulinLack of efficacy: case report
Reactions Weekly, 2025, 2044 (1) : 130 - 130
[37] Doxorubicin/doxycyclineLack of efficacy : case report
Reactions Weekly, 2024, 2017 (1) : 180 - 180
[38] Doxorubicin/pazopanibLack of efficacy: case report
Reactions Weekly, 2023, 1983 (1) : 183 - 183
[39] IfosfamideLack of efficacy
Reactions Weekly, 2024, 2004 (1) : 235 - 235
[40] Catequentinib/ifosfamideLack of efficacy: 12 case reports
Reactions Weekly, 2025, 2047 (1) : 109 - 109

← 1 2 3 4 5 →